跳至主要内容
临床试验/ACTRN12613000377730
ACTRN12613000377730已完成3 期

A comparative study of sequential therapy and 10-day standard triple therapy for Helicobacter pylori infection eradication: a randomized, open-label, multicentre trial in Chinese naive patients

Sanren Lin0 个研究点目标入组 280 人开始时间: 2013年4月9日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Consecutive patients with dyspepsia who had been referred for upper endoscopy at four tertiary hospitals in Beijing, Shanghai, Wuhan and Guangzhou were included in the study. Patients with positive Helicobacter pylori cultures were recruited into the study. None of the patients had previously received treatment for Helicobacter pylori infection.

排除标准

  • Patients who had received proton pump inhibitor, H2-receptor blockers, bismuth salts or antibiotics in the previous 4 weeks were excluded from entering the study. None of the patients had a history of gastrointestinal malignancy, previous gastric or esophageal surgery, Zollinger-Ellison syndrome, severe concomitant cardiovascular, respiratory, hematological, renal, hepatic or neurological diseases. Women who were pregnant or lactating were excluded from the study, as were those known to be allergic to any of the study drugs.

研究者

发起方
Sanren Lin

相似试验